Commonwealth Equity Services
PMN icon

Commonwealth Equity Services’s ProMIS Neurosciences PMN Stock Holding History

Commonwealth Equity Services’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-458
Closed -$5K – 4412
2025
Q3 		$5K Hold
458
– – ﹤0.01% 4230
2025
Q2 		$6K Buy
+458
New +$6.25K ﹤0.01% 4241

Other funds holding PMN

ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
DEM
Disciplined Equity Management Neptune Beach, Florida $226M AUM 27.21% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Commonwealth Equity Services's PMN Position: Q4 2025 in Review

Commonwealth Equity Services sold out of ProMIS Neurosciences (PMN) in Q4 2025, closing a stake of 458 shares — an estimated $5K sold.

Commonwealth Equity Services first reported a position in PMN in Q2 2025 and held it in 2 quarters. The position peaked at $6K in Q2 2025. 9 funds tracked by Wall St. Rank hold PMN as of Q4 2025.

  • Commonwealth Equity Services reported no remaining ProMIS Neurosciences position as of Q4 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 458 ProMIS Neurosciences shares in Q4 2025, an estimated $5K.
  • Commonwealth Equity Services first reported a position in ProMIS Neurosciences in Q2 2025 and held it in 2 quarters.
  • Commonwealth Equity Services's ProMIS Neurosciences position peaked at $6K in Q2 2025.
  • 9 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q4 2025.

Based on Commonwealth Equity Services's 13F filing for Q4 2025, filed 12 Feb 2026.